I am pleased to present the Second Regional Educational Meeting on Supportive Care in Cancer Patients for Eastern Europe and the Balkan Region, which was held on 1-2 December 2017 in Belgrade. Research professor Snezana Bosniak represented the Institute of Oncology from Belgrade, and had many invited speakers from Europe and USA: M. Aapro, J. Herrstedt, S. Ahmedzai, Marcin Janecki, A. Vadalouca, Alexandru C. Grigorescu, C. Ripamonti, C. Donnellan, A. Fusi, F. Bozzetti, S. Barni, F. Roila, R. Gralla, R. Vrhovac, J. Crawford, and H. Link.
The meeting was organized by the Serbian Society for Medical Oncology, and was held under the auspices of The Multinational Society for Supportive Care in Cancer (MASCC), with the support of The European School of Oncology (ESO) and The European Society of Gynecological Oncology (ESGO).
The meeting was designed to promote supportive care as an integral part of comprehensive cancer care and present current supportive care guidelines, and to facilitate their clinical interpretation and implementation in routine practice. The targeted audience was oncologists with an interest in supportive oncology and palliative care. Topics were selected to cover the prevention and management of cancer-induced symptoms and complications, and also toxicities from cancer treatment, which were addressed by invited lectures, case presentations and discussions with experts, as well as during interactive workshops to discuss different models of integration of supportive and palliative care into oncology in the region.
Over 150 participants and lecturers re­pre­senting 21 countries attended the first meeting in 2016 and the participants highly valued the inspiring lectures, the ap­proachability of the speakers, and the lively debates.
Furthermore, the meeting was accredited with 12 Category 1 ESMO-MORA points.
The main subjects discussed were: In­te­grated model of supportive care ser­vice - Denmark; Integrated model of sup­portive care service - Romania; Pain in patients with multiple myeloma; Cancer pain - breakthrough pain; Cancer pain - interventional approaches; Highly Emetogenic Chemotherapy; Olanzapine - pre­vention and control of nausea and vo­mi­­ting; Optimal management of immune-re­lated adverse events; Nutritional support as a part of best supportive care for patients with advanced cancer; The use of WBC growth factors. 
The example of the Belgrade Oncology Institute and the medical oncology society from Serbia is worth mentioning. Also, I think a cooperation with my colleagues from Serbia, which I initiated, should be continued. 
In conclusion, because this is the last number of our journal this year, I want to thank all those who have sent valuable materials for publication and wish them happy holidays!editorial